Jacqueline Aredo, MD, MS

Title(s)RESIDENT, Medicine
SchoolSchool of Medicine
Phone--
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study. J Thorac Oncol. 2024 Jan 24. Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin SH, Abuali T, Amini A, Nie Y, Patil T, Lobachov A, Bar J, Fitzgerald B, Fujiwara Y, Marron TU, Thummalapalli R, Yu H, Owen DH, Sharp J, Farid S, Rocha P, Arriola E, D'Aiello A, Cheng H, Whitaker R, Parikh K, Ashara Y, Chen L, Sankar K, Harris JP, Nagasaka M, Ayanambakkam A, Velazquez AI, Ragavan M, Lin JJ, Piotrowska Z, Wilgucki M, Reuss J, Luders H, Grohe C, Baena Espinar J, Feiner E, Punekar SR, Gupta S, Leal T, Kwiatkowski DJ, Mak RH, Adib E, Naqash AR, Goldberg SB. PMID: 38278303.
      View in: PubMed   Mentions:    Fields:    
    2. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US. JAMA Oncol. 2023 Dec 01; 9(12):1640-1648. Choi E, Ding VY, Luo SJ, Ten Haaf K, Wu JT, Aredo JV, Wilkens LR, Freedman ND, Backhus LM, Leung AN, Meza R, Lui NS, Haiman CA, Park SL, Le Marchand L, Neal JW, Cheng I, Wakelee HA, Tammemägi MC, Han SS. PMID: 37883107; PMCID: PMC10603577.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked. JAMA Netw Open. 2023 Nov 01; 6(11):e2343278. Choi E, Su CC, Wu JT, Aredo JV, Neal JW, Leung AN, Backhus LM, Lui NS, Le Marchand L, Stram DO, Liang SY, Cheng I, Wakelee HA, Han SS. PMID: 37966839; PMCID: PMC10652150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model. Cancer. 2024 Mar 01; 130(5):770-780. Choi E, Luo SJ, Ding VY, Wu JT, Kumar AV, Wampfler J, Tammemägi MC, Wilkens LR, Aredo JV, Backhus LM, Neal JW, Leung AN, Freedman ND, Hung RJ, Amos CI, Le Marchand L, Cheng I, Wakelee HA, Yang P, Han SS. PMID: 37877788.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC. Cancer Discov. 2023 07 07; 13(7):1556-1571. Negrao MV, Araujo HA, Lamberti G, Cooper AJ, Akhave NS, Zhou T, Delasos L, Hicks JK, Aldea M, Minuti G, Hines J, Aredo JV, Dennis MJ, Chakrabarti T, Scott SC, Bironzo P, Scheffler M, Christopoulos P, Stenzinger A, Riess JW, Kim SY, Goldberg SB, Li M, Wang Q, Qing Y, Ni Y, Do MT, Lee R, Ricciuti B, Alessi JV, Wang J, Resuli B, Landi L, Tseng SC, Nishino M, Digumarthy SR, Rinsurongkawong W, Rinsurongkawong V, Vaporciyan AA, Blumenschein GR, Zhang J, Owen DH, Blakely CM, Mountzios G, Shu CA, Bestvina CM, Garassino MC, Marrone KA, Gray JE, Patel SP, Cummings AL, Wakelee HA, Wolf J, Scagliotti GV, Cappuzzo F, Barlesi F, Patil PD, Drusbosky L, Gibbons DL, Meric-Bernstam F, Lee JJ, Heymach JV, Hong DS, Heist RS, Awad MM, Skoulidis F. PMID: 37068173.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    6. Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations. Clin Cancer Res. 2023 06 01; 29(11):2123-2130. Grant MJ, Aredo JV, Starrett JH, Stockhammer P, van Alderwerelt van Rosenburgh IK, Wurtz A, Piper-Valillo AJ, Piotrowska Z, Falcon C, Yu HA, Aggarwal C, Scholes D, Patil T, Nguyen C, Phadke M, Li FY, Neal J, Lemmon MA, Walther Z, Politi K, Goldberg SB. PMID: 36913537; PMCID: PMC10493186.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    7. Implementation and evaluation of an elective quality improvement curriculum for preclinical students: a prospective controlled study. BMC Med Educ. 2023 Jan 26; 23(1):66. Aredo JV, Ding JB, Lai CH, Trimble R, Bromley-Dulfano RA, Popat RA, Shieh L. PMID: 36703204.
      View in: PubMed   Mentions:    Fields:    
    8. Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study. JTO Clin Res Rep. 2023 Mar; 4(3):100459. Ji J, Aredo JV, Piper-Vallillo A, Huppert L, Rotow JK, Husain H, Stewart S, Cobb R, Wakelee HA, Blakely CM, Wong ML, Gubens MA, Madani MH, Digumarthy SR, McCoach C, Piotrowska Z, Neal JW, Riess JW. PMID: 36879929; PMCID: PMC9984841.
      View in: PubMed   Mentions: 7  
    9. Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer. Cancer Treat Res Commun. 2022; 33:100659. Aredo JV, Wakelee HA, Hui AB, Padda SK, Joshi ND, Guo HH, Chaudhuri A, Diehn M, Loo BW, Neal JW. PMID: 36427429.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study. JNCI Cancer Spectr. 2022 05 02; 6(3). Aredo JV, Choi E, Ding VY, Tammemägi MC, Ten Haaf K, Luo SJ, Freedman ND, Wilkens LR, Le Marchand L, Wakelee HA, Meza R, Park SL, Cheng I, Han SS. PMID: 35642317; PMCID: PMC9156850.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    11. High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience. JTO Clin Res Rep. 2022 Jun; 3(6):100328. Piper-Vallillo AJ, Rotow JK, Aredo JV, Shaverdashvili K, Luo J, Carlisle JW, Husain H, Muzikansky A, Heist RS, Rangachari D, Ramalingam SS, Wakelee HA, Yu HA, Sequist LV, Bauml JM, Neal JW, Piotrowska Z. PMID: 35637759; PMCID: PMC9142556.
      View in: PubMed   Mentions: 15  
    12. The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):618-625. Choi E, Luo SJ, Aredo JV, Backhus LM, Wilkens LR, Su CC, Neal JW, Le Marchand L, Cheng I, Wakelee HA, Han SS. PMID: 34893871; PMCID: PMC9002287.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    13. Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer. J Natl Cancer Inst. 2022 01 11; 114(1):87-96. Choi E, Sanyal N, Ding VY, Gardner RM, Aredo JV, Lee J, Wu JT, Hickey TP, Barrett B, Riley TL, Wilkens LR, Leung AN, Le Marchand L, Tammemägi MC, Hung RJ, Amos CI, Freedman ND, Cheng I, Wakelee HA, Han SS. PMID: 34255071; PMCID: PMC8755509.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    14. Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer. Cancer Treat Res Commun. 2022; 30:100497. Aredo JV, Wakelee HA, Neal JW, Padda SK. PMID: 34920242.
      View in: PubMed   Mentions: 4     Fields:    
    15. Consolidation Durvalumab Should Not Be Administered to Patients With Stage III EGFR-Mutant NSCLC. J Thorac Oncol. 2021 12; 16(12):1994-1998. Aredo JV, Hellyer JA, Neal JW, Wakelee HA. PMID: 34809803.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS-Mutated Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2021 11; 5:153-162. Padda SK, Aredo JV, Vali S, Singh NK, Vasista SM, Kumar A, Neal JW, Abbasi T, Wakelee HA. PMID: 34994595.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study. JNCI Cancer Spectr. 2021 10; 5(5). Luo SJ, Choi E, Aredo JV, Wilkens LR, Tammemägi MC, Le Marchand L, Cheng I, Wakelee HA, Han SS. PMID: 34611582; PMCID: PMC8487318.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. A Moving Target: Integration of Smoking Cessation Into Screening for Second Primary Lung Cancer. J Thorac Oncol. 2021 08; 16(8):e59-e60. Aredo JV, Wakelee HA, Han SS. PMID: 34304856; PMCID: PMC8628550.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    19. EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy. Clin Lung Cancer. 2022 03; 23(2):e148-e153. Shah MP, Aredo JV, Padda SK, Ramchandran KJ, Wakelee HA, Das MS, Neal JW. PMID: 34391686; PMCID: PMC8766618.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    20. Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 2021 06; 16(6):968-979. Aredo JV, Luo SJ, Gardner RM, Sanyal N, Choi E, Hickey TP, Riley TL, Huang WY, Kurian AW, Leung AN, Wilkens LR, Robbins HA, Riboli E, Kaaks R, Tjønneland A, Vermeulen RCH, Panico S, Le Marchand L, Amos CI, Hung RJ, Freedman ND, Johansson M, Cheng I, Wakelee HA, Han SS. PMID: 33722709; PMCID: PMC8159872.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    21. Metabolomic profiling for second primary lung cancer: A pilot case-control study. Lung Cancer. 2021 05; 155:61-67. Aredo JV, Purington N, Su L, Luo SJ, Diao N, Christiani DC, Wakelee HA, Han SS. PMID: 33743383; PMCID: PMC8085101.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy. J Thorac Oncol. 2021 06; 16(6):1030-1041. Aredo JV, Mambetsariev I, Hellyer JA, Amini A, Neal JW, Padda SK, McCoach CE, Riess JW, Cabebe EC, Naidoo J, Abuali T, Salgia R, Loo BW, Diehn M, Han SS, Wakelee HA. PMID: 33588109.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    23. Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC. J Thorac Oncol. 2021 05; 16(5):868-872. Hellyer JA, Aredo JV, Das M, Ramchandran K, Padda SK, Neal JW, Wakelee HA. PMID: 33539970.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    24. Widespread myofascial dysfunction and sensitisation in women with endometriosis-associated chronic pelvic pain: A cross-sectional study. Eur J Pain. 2021 04; 25(4):831-840. Phan VT, Stratton P, Tandon HK, Sinaii N, Aredo JV, Karp BI, Merideth MA, Shah JP. PMID: 33326662; PMCID: PMC7979491.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    25. Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report. Clin Lung Cancer. 2021 09; 22(5):e673-e677. Aredo JV, Diehn M, Berry GJ, Wakelee HA. PMID: 33451914.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes". Lung Cancer. 2019 11; 137:159-160. Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA. PMID: 31492438.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes. Lung Cancer. 2019 07; 133:144-150. Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA. PMID: 31200821; PMCID: PMC9348589.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    28. Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study. World Neurosurg. 2019 05; 125:e487-e496. Huang Y, Chow KKH, Aredo JV, Padda SK, Han SS, Kakusa BW, Hayden Gephart M. PMID: 30710723; PMCID: PMC9348783.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine. Curr Treat Options Oncol. 2018 06 27; 19(8):43. Aredo JV, Padda SK. PMID: 29951788.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Relating Chronic Pelvic Pain and Endometriosis to Signs of Sensitization and Myofascial Pain and Dysfunction. Semin Reprod Med. 2017 01; 35(1):88-97. Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. PMID: 28049214; PMCID: PMC5585080.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    31. Beneficial Effects of Dry Needling for Treatment of Chronic Myofascial Pain Persist for 6 Weeks After Treatment Completion. PM R. 2017 02; 9(2):105-112. Gerber LH, Sikdar S, Aredo JV, Armstrong K, Rosenberger WF, Shao H, Shah JP. PMID: 27297448; PMCID: PMC5149452.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective. PM R. 2015 Jul; 7(7):746-761. Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L. PMID: 25724849; PMCID: PMC4508225.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Jacqueline's Networks
    Concepts (106)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.